Sign up free

TAKEDA PHARMACEUTICAL CO LTD (TAK) insider trading

No open-market insider purchases of TAKEDA PHARMACEUTICAL CO LTD are on record; 1 open-market sale is.

Follow TAK, freeOpen the live feed

A free account gets an alert the minute a new buy or sale is filed.

−$640knet insider buying, 90 days
−$640knet insider buying, 12 months
0 · 1insiders buying · selling, 12 months
—no buys on record

Insider purchases

No open-market purchases on record.

Insider sales

1 open-market sale on record
FiledInsiderSold
Sep 16
Form 4 (opens sec.gov)
Lauren Rusckowski DupreyChief Transformation Officer $640k
34,535 at $18.54 · 15% of holdings

Most insider sales are planned in advance or made for personal reasons, so a sale says less than a buy.

TAK trades reported by members of Congress

ReportedMemberTradeAmount
Jul 21Alan ArmstrongR-OK · Senate113 days after the tradeBuy$1K–$15K

Members of Congress report trades up to 45 days later, in dollar ranges. Every member's trades.

Planned insider sales of TAK (Form 144)

FiledInsiderTo sell
Oct 30
Form 144
Platford Giles RichardPresident, International Business Unit · no trading plan named$1.1M
55,617 shares from Nov 1
Oct 30
Form 144
Teresa BitettiPresident, Global Oncology Business Unit · no trading plan named$940k
46,609 shares from Nov 1

A Form 144 is filed before an insider sells restricted or control shares; the Form 4 reports the sale once made.

Questions

Are insiders buying TAK stock?

Not recently: no open-market purchases were filed in the last 90 days.

Who bought TAK stock most recently?

No insider has bought TAK on the open market in the filings on record.

How does InsiderBeacon score an insider buy?

Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.

Data as of Sep 16, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer

Follow insiders. Sell when they sell.Free in early access, no card

Sign up free